Skip to main content
. 2026 Apr 10;15(3):1357–1374. doi: 10.1007/s40120-026-00936-w

Table 2.

Treatment outcomes during the clinical trial period

Treatment outcomes: raw score
Baseline After Tx Changea (base ~ Tx) p Value After F/u Changeb (base ~ F/u) p Value
ISI
 PC 17.59 ± 3.95 7.13 ± 4.45 10.46 ± 5.05 0.005 6.96 ± 4.45 10.63 ± 4.85 0.007
 CA 16.30 ± 3.69 8.12 ± 4.03 8.19 ± 3.79 8.00 ± 4.03 8.30 ± 4.32
HINT-8
 PC 0.786 ± 0.091 0.823 ± 0.088 0.037 ± 0.071 0.676 0.823 ± 0.010 0.037 ± 0.074 0.319
 CA 0.788 ± 0.072 0.821 ± 0.075 0.033 ± 0.042 0.813 ± 0.088 0.024 ± 0.063
Treatment outcomes: remission rate
Baseline ~ after Tx Baseline ~ after F/u
No./total No./total
PC 53/82d (64.4%) 50/82d (61.0%)
CA 25/43 (58.1%) 19/43 (44.2%)

Tx, treatment; F/u, follow-up; PC, pharmacopuncture; CA, conventional acupuncture (traditional acupuncture, electroacupuncture); ISI, Insomnia Severity Index; HINT-8, Health-related Quality of Life Instrument with Eight Items

aChange from baseline to post treatment

bChange from baseline to end of follow-up

cRemission defined as Insomnia Severity Index score < 8

dParticipants with baseline ISI < 8 excluded from remission analysis